Anuh Pharma Limited (BOM:506260)
India · Delayed Price · Currency is INR 80.72
+1.59 (2.01%)
At close: Jul 27, 2026
Anuh Pharma Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 7,717 | 7,717 | 6,615 | 6,470 | 5,275 | 4,866 |
Revenue Growth | 16.65% | 16.65% | 2.24% | 22.66% | 8.39% | 12.66% |
Gross Profit Gross Profit Growth | 1,631 | 1,631 | 1,548 | 1,556 | 1,200 | 1,057 |
Operating Income Operating Income Growth | 564.6 | 564.6 | 549.51 | 668.73 | 437.21 | 365.35 |
Net Income Net Income Growth | 410.46 | 410.46 | 473.52 | 600.58 | 361.8 | 305.61 |
Earnings Per Share EPS Growth | 4.10 | 4.10 | 9.45 | 5.99 | 3.61 | 3.05 |
EPS Growth | -56.66% | -56.66% | 57.69% | 66.00% | 18.38% | 7.47% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Export Export Growth | 3,548 | 3,548 | 3,634 | 3,041 | 2,893 | 2,280 |
India India Growth | 4,169 | 4,169 | 2,981 | 3,429 | 2,381 | 2,587 |
Total Total Growth | 7,717 | 7,717 | 6,615 | 6,470 | 5,275 | 4,866 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 529.19 | 529.19 | 734.15 | 622.56 | 530.77 | 252.65 |
Total Debt Total Debt Growth | 0.58 | 0.58 | 108.86 | 26.93 | 9.07 | 42.24 |
Net Cash (Debt) Net Cash Growth | 528.61 | 528.61 | 625.28 | 595.63 | 521.7 | 210.41 |
Net Cash Growth | -15.46% | -15.46% | 4.98% | 14.17% | 147.94% | - |
Net Cash Per Share Net Cash Per Share Growth | 5.27 | 5.27 | 12.48 | 5.94 | 5.21 | 2.10 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -30.12 | -30.12 | 371.25 | 129.25 | 539.02 | 288.64 |
Capital Expenditures CapEx Growth | -78.69 | -78.69 | -201.46 | -50.17 | -15.5 | -16.15 |
Free Cash Flow Free Cash Flow Growth | -108.8 | -108.8 | 169.79 | 79.09 | 523.52 | 272.49 |
Free Cash Flow Growth | - | - | 114.69% | -84.89% | 92.12% | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 21.13% | 21.13% | 23.40% | 24.05% | 22.74% | 21.72% |
Operating Margin | 7.32% | 7.32% | 8.31% | 10.34% | 8.29% | 7.51% |
Pretax Margin | 7.03% | 7.03% | 9.22% | 12.10% | 9.00% | 8.04% |
Profit Margin | 5.32% | 5.32% | 7.16% | 9.28% | 6.86% | 6.28% |
FCF Margin | -1.41% | -1.41% | 2.57% | 1.22% | 9.93% | 5.60% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.500 | 1.500 | 1.500 | 1.250 | 1.000 | 0.875 |
Dividend Per Share Growth | 0% | 0% | 20.00% | 25.00% | 14.29% | 16.67% |
Dividend Yield | 1.90% | 2.23% | 2.05% | 1.05% | 2.63% | 2.17% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 19.71 | 16.39 | 15.75 | 20.49 | 11.03 | 14.09 |
P/FCF Ratio | - | - | 43.93 | 155.62 | 7.62 | 15.81 |
PS Ratio | 1.05 | 0.87 | 1.13 | 1.90 | 0.76 | 0.89 |